Simcere

1 trends tracked about this subject — the full history, oldest to newest below.

↑ Rising Business

Roche has entered a $1.53 billion exclusive global licensing agreement with Simcere for the B-cell-targeting antibody SIM0660.

8 sources 11 articles v 8 3m ago